文献速递重症综合管理与镇静镇痛呼吸衰竭与机械通气

允许性低喂养与标准肠内喂养对需机械通气重症患者结局的影响:一项前瞻性随机对照研究

[Impact of permissive underfeeding versus standard enteral feeding on outcomes in critical patients requiring mechanical ventilation: a prospective randomized controlled study].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2018-01-01
一句话结论在需机械通气的重症患者中,允许性低喂养(每日能量需求的50%)与标准肠内喂养(100%)相比,疗效与预后相似,但允许性低喂养可减少胰岛素用量并改善胃肠道耐受性。

该前瞻性随机对照研究纳入2015年1月至2017年3月安吉县人民医院ICU收治的82例需机械通气的重症患者,随机分为允许性低喂养组(n=40,非蛋白热卡52.3-62.8 kJ×kg-1×d-1,蛋白质1.2-1.5 g×kg-1×d-1)和标准肠内喂养组(n=42,非蛋白热卡104.6-125.5 kJ×kg-1×d-1,蛋白质1.2-1.5 g×kg-1×d-1)。允许性低喂养组在入ICU后24-48小时内经肠内营养提供每日能量消耗的50%,标准肠内喂养组提供100%。结果显示,治疗7天后两组前白蛋白、白蛋白均较治疗前显著升高,降钙素原、超敏C反应蛋白均显著降低(均P<0.05),但两组间上述指标无显著差异(均P>0.05)。两组机械通气时间、ICU住院时间、28天死亡率、ICU相关感染率均无显著差异(均P>0.05)。与标准肠内喂养组相比,允许性低喂养组胰岛素需求量显著减少(13.68±10.36 U/d vs. 26.24±18.53 U/d),胃肠道不耐受发生率更低(32.5% vs. 54.8%),差异均有统计学意义(均P<0.05)。Kaplan-Meier生存曲线分析显示两组无显著差异(χ2=3.216,P=0.068)。结论认为,允许性低喂养对需机械通气重症患者的疗效和预后与标准肠内喂养相似,但可减少胰岛素用量并具有更好的胃肠道耐受性。

要点

  • 允许性低喂养组在入ICU后24-48小时内经肠内营养提供每日能量消耗的50%,标准肠内喂养组提供100%,两组蛋白质均为1.2-1.5 g×kg-1×d-1。
  • 两组治疗7天后前白蛋白、白蛋白均较治疗前显著升高,降钙素原、超敏C反应蛋白均显著降低(均P<0.05),但组间比较均无显著差异(均P>0.05)。
  • 两组机械通气时间(162.35±20.37小时 vs. 153.48±18.65小时)、ICU住院时间(7.52±1.61天 vs. 6.34±1.87天)、28天死亡率(17.5% vs. 19.0%)、ICU相关感染率(45.0% vs. 47.6%)均无显著差异(均P>0.05)。
  • 允许性低喂养组胰岛素需求量显著低于标准肠内喂养组(13.68±10.36 U/d vs. 26.24±18.53 U/d,P<0.05),胃肠道不耐受发生率也更低(32.5% vs. 54.8%,P<0.05)。
  • Kaplan-Meier生存曲线分析显示两组生存率无显著差异(χ2=3.216,P=0.068)。

适用人群与场景

  • 2015年1月至2017年3月安吉县人民医院ICU收治的需机械通气的重症患者82例,随机分为允许性低喂养组(n=40)和标准肠内喂养组(n=42)。

处置流程与药物剂量

  • 允许性低喂养组:入ICU后24-48小时内经肠内营养提供每日能量消耗的50%,非蛋白热卡52.3-62.8 kJ×kg-1×d-1,蛋白质1.2-1.5 g×kg-1×d-1。
  • 标准肠内喂养组:入ICU后24-48小时内经肠内营养提供每日能量消耗的100%,非蛋白热卡104.6-125.5 kJ×kg-1×d-1,蛋白质1.2-1.5 g×kg-1×d-1。

研究设计与关键结果

  • 研究类型:前瞻性随机对照研究;样本量82例;单中心(安吉县人民医院ICU);人群:需机械通气的重症患者;干预:允许性低喂养(每日能量消耗的50%)vs. 标准肠内喂养(100%)。
  • 主要终点结果:治疗7天后两组前白蛋白、白蛋白均较治疗前显著升高,降钙素原、超敏C反应蛋白均显著降低(均P<0.05),但组间比较均无显著差异(均P>0.05)。
  • 允许性低喂养组治疗前后:前白蛋白127.42±65.83 mg/L vs. 80.92±60.14 mg/L,白蛋白30.16±4.32 g/L vs. 25.36±6.21 g/L,降钙素原375.8±227.2 ng/L vs. 762.3±314.5 ng/L,超敏C反应蛋白32.19±7.53 mg/L vs. 120.48±60.24 mg/L(均P<0.05)。
  • 标准肠内喂养组治疗前后:前白蛋白132.56±61.32 mg/L vs. 86.78±47.06 mg/L,白蛋白31.25±4.63 g/L vs. 26.71±5.48 g/L,降钙素原412.1±323.4 ng/L vs. 821.7±408.6 ng/L,超敏C反应蛋白35.86±5.69 mg/L vs. 116.38±72.16 mg/L(均P<0.05)。
  • 两组机械通气时间(小时):162.35±20.37 vs. 153.48±18.65,ICU住院时间(天):7.52±1.61 vs. 6.34±1.87,28天死亡率:17.5% vs. 19.0%,ICU相关感染率:45.0% vs. 47.6%,均无显著差异(均P>0.05)。
  • 与标准肠内喂养组相比,允许性低喂养组胰岛素需求量显著减少(13.68±10.36 U/d vs. 26.24±18.53 U/d,P<0.05),胃肠道不耐受发生率更低(32.5% vs. 54.8%,P<0.05)。
  • Kaplan-Meier生存曲线分析显示两组无显著差异(χ2=3.216,P=0.068)。

证据类型、等级与局限

  • 证据类型:前瞻性随机对照研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,对需机械通气的重症患者,允许性低喂养的疗效和预后与标准肠内喂养相似,但可减少胰岛素用量并具有更好的胃肠道耐受性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To compare the impact of permissive underfeeding versus standard enteral feeding on outcomes in critical patients requiring mechanical ventilation (MV).

METHODS: A prospective randomized controlled study was conducted. Eighty-two patients requiring MV admitted to intensive care unit (ICU) of Anji People's Hospital from January 2015 to March 2017 were enrolled, and they were randomly divided into the permissive underfeeding group (n = 40, non-protein heat was 52.3-62.8 kJ×kg-1×d-1, protein was 1.2-1.5 g×kg-1×d-1) and standard enteral feeding group (n = 42, non-protein heat was 104.6-125.5 kJ×kg-1×d-1, protein was 1.2-1.5 g×kg-1×d-1). Permissive underfeeding group received 50% of their daily energy expenditure via enteral nutrition (EN) and standard enteral feeding group received 100% of their daily energy expenditure via EN in 24-48 hours after admitted to ICU. Nutritional status [pro-albumin (PA), serum albumin (ALB)], inflammation state [procalcitonin (PCT), hypersensitive C-reactive protein (hs-CRP)] were detected before treatment and 7 days after treatment. Duration of MV, length of ICU stay, daily insulin dosage, 28-day mortality, hospital acquired pneumonia (HAP), urinary tract infection, septic shock and other secondary infection, and the nutrition related complications were recorded.

RESULTS: Compared with before treatment, the levels of serum PA (mg/L) and ALB (g/L) were significantly increased, the levels of PCT (ng/L) and hs-CRP (mg/L) were significantly decreased at 7 days after treatment in both groups [permissive underfeeding group: PA was 127.42±65.83 vs. 80.92±60.14, ALB was 30.16±4.32 vs. 25.36±6.21, PCT was 375.8±227.2 vs. 762.3±314.5, hs-CRP was 32.19±7.53 vs. 120.48±60.24; standard enteral feeding group: PA was 132.56±61.32 vs. 86.78±47.06, ALB was 31.25±4.63 vs. 26.71±5.48, PCT was 412.1±323.4 vs. 821.7±408.6, hs-CRP was 35.86±5.69 vs. 116.38±72.16, all P < 0.05], but there was no significant difference in PA, ALB, PCT or hs-CRP at 7 days after treatment between two groups (all P > 0.05). There was no significant difference in the duration of MV, length of ICU stay, 28-day mortality or ICU-associated infection between two groups [duration of MV (hours): 162.35±20.37 vs. 153.48±18.65, length of ICU stay (days): 7.52±1.61 vs. 6.34±1.87, 28-day mortality: 17.5% vs. 19.0%, ICU-associated infection: 45.0% vs. 47.6%, all P > 0.05]. Compared with standard enteral feeding, insulin demand was significantly decreased (U/d: 13.68±10.36 vs. 26.24±18.53), and gastrointestinal intolerance was less frequent (32.5% vs. 54.8%) in the permissive underfeeding group (both P < 0.05). Kaplan-Meier survival curve analysis showed that there was no significant difference between the two groups (χ2 = 3.216, P = 0.068).

CONCLUSIONS: The curative effect and prognosis of MV severe patients receiving permissive underfeeding are similar to those of standard enteral feeding, but it can reduce the dosage of insulin with better gastrointestinal tolerance.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Ma N, Shen M, Wan Z, et al. [Impact of permissive underfeeding versus standard enteral feeding on outcomes in critical patients requiring mechanical ventilation: a prospective randomized controlled study]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018. PMID: 29402370. doi:10.3760/cma.j.issn.2095-4352.2018.02.016

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。